for the underlying vial-size principles, see Peptide Vial Sizes Explained
(2014) Safety and efficacy of intravenous ultra-high dose methylcobalamin treatment for peripheral neuropathy: a phase I/II open label clinical trial
For retroviral based hiPSC generation, hOCT4, hSOX2, hKLF4 and hcMYC, retrovirus viral particles were purchased from Vectalys and transduced at an MOI of 5 as previously described by Vallier and colleagues 48
Subsequently, 1 M dihydroethidium (DHE) was added to the medium and further incubated for 30 min
Ali HS, Kamel R, El-Gizawy SA
Just keep expectations realistic: the research so far comes from small NAFLD studiesnot specific to PCOS or menopausal womenso we still need larger trials before calling it a proven fix